Opinion: Prasad’s FDA exit good for rare diseases but new CBER head must repair eroded trust BioSpace
COMMENTS (0)
Epstein housed victims in London flats after Met chose not to investigate him, BBC revealsSteve Rosenberg: Kremlin's tightening grip on internet fuels public discontentStock markets are too high and set to fall, says Bank of England deputyAssisted dying bill to run out of time as Lords hold final debateRingo Starr: 'I made all my mistakes on stage'Staff at UK's largest Pride event allege bullying and misconduct under sacked CEOTrump says he speaks 'for the UK more than Prince Harry'US soldier charged after winning $400,000 betting on removal of MaduroSouthport dads: 'Running for our girls has made us like brothers'Singer D4vd had 'significant amount' of child sex abuse images when arrested, prosecutors sayCouple discovers Lebanon home destroyed by Israel from satellite imageWeekly quiz: What did Madonna lose at Coachella?Headscarf with a beret: Muslim designers showcase floral dresses and boxy streetwear in ParisThe Papers: 'Stop sharing data with China' and 'Shoot and kill''Missing scientist' cases have stoked wild speculation. For loved ones, the theories are hurtfulFirst ever talks to ditch fossil fuels as UN deadlock deepensUS government watchdog to investigate Epstein files releaseThree men guilty of 'callous' Brighton beach rapeMeta says it will cut 8,000 jobs as AI spending soarsHealth data of 500,000 people offered for sale online in China after UK Biobank breachPC Andrew Harper's widow unveils 'hero' memorialPM's ex-chief of staff says he doesn't recognise claims about his behaviourBBC News appDonald Trump gets on the phone... with SarahThe Week: How Much Danger Is Keir Starmer In?Who will win title? The big prediction specialRaiders take Mendoza with first pick of NFL DraftLittler cuts gap to Clayton with win in LiverpoolSeason has been big learning experience - TraffordBig clubs and big names - a summer of managerial upheaval awaits
Leave a Comment